valsartan / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

34 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
valsartan / Generic mfg.
ChiCTR-IOR-16008847: Clinical Study of Huangqi Decoction/Astragalus Decoction in the Treatment of 'Qi-Yin Vital Essence Deficiency' Type DKD III Patients

Recruiting
N/A
240
 
astragalus decoction, valsartan ;valrtan,placebo
Shanghai Putuo District Central Hospital; Shanghai Putuo District Central Hospital, Shanghai Health Family Planning Committee “Three -Year Action Plan of Chinese Medicine Pharmaceutical Development in Shanghai” Project Number:ZY3-CCCX-3-3003
Diabetic nephropathy
 
 
ChiCTR-IOR-16010174: Clinical Study on Treatment of spleen and kidney Yang deficiency type of IgA nephropathy proteinuria with 'Huangqi guizhi wuwu' decoction

Recruiting
N/A
100
 
Basic treatment+Valsartan Capsules treatment ;Basic treatment+Huangqi guizhi wuwu decoction treatment
Shuguang Hospital affliliated to Shanghai Univesrity of TCM; Shuguang Hospital affliliated with shanghai Univesrity of TCM, The municipal fiscal funds and unit self-raised funds
IgA nephropathy
 
 
ChiCTR-INR-17011060: Shendi Granules on PBMC apoptosis and MCP-1, TGF- beta 1 in chronic glomerulonephritis patients with spleen and kidney deficiency syndrome

Not yet recruiting
N/A
60
 
conventional therapy+Shendi Granules ;conventional therapy+Valsartan
the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine; Level of the institution:, Self financing
Chronic glomerulonephritis
 
 
ChiCTR-IOR-17012079: Human bioequivalence test of Valsartan and Amlodipine Tablets (I)

Recruiting
N/A
72
 
Valsartan and Amlodipine Tablets (I) ;缬沙坦氨氯地平片(I)
West China Hospital, Sichuan University; West China Hospital, Sichuan University, independently
高血压
 
 
ChiCTR-INR-17012070: Yongquan acupoint Shenque moxibustion curative effect of traditional Chinese medicine in the treatment of membranous nephropathy

Not yet recruiting
N/A
150
 
Yongquan Shenque paste of Chinese medicine with mild moxibustion ;Valsartan Tablets
Shijiazhuang Nephropathy Hospital; Shijiazhuang Nephropathy Hospital, raise independently
Membranous nephropathy
 
 
ChiCTR-OOD-17013741: Effect of fully blocking type 1 angiotensin receptor on blood pressure, cardiac structure, cardiac function and cognitive function in postmenopausal hypertensive women

Not yet recruiting
N/A
98
 
Different doses of valsartan
Lanzhou University Second Hospital; Lanzhou University Second Hospital, Scientific research project of Gansu health industry
hypertension
 
 
ChiCTR2000041383: Single-center, randomized open clinical trial of the clinical efficacy and safety of Sakubatravalsartan Sodium Tablets (Noxinto) 100mg, bid in the early application of PCI after acute myocardial infarction

Recruiting
N/A
70
 
Valsartan ;Sacurbacter Valsartan
Department of Cardiology, Tangdu Hospital; Tangdu Hospital, Fourth Military Medical University, none
Acute myocardial infarction
 
 
ChiCTR2000030912: Clinical observation of Dachaihu decoction in the treatment of Irascibility hyperactivity syndrome(overabundant liver-fire syndrom) of hypertension

Not yet recruiting
N/A
194
 
Dachaihu soup granule formula ;Valsartan capsule
Affiliated Hospital of Shandong University of TCM; Affiliated Hospital of Shandong University of TCM, Shandong development and reform commission
Essential hypertension
 
 
ChiCTR2000031060: The Network Pharmacology and Mechanism Analysis of Xianxiong Chengqi Decoction in Treating Hypertension with Phlegm and Blood Stasis Syndrome

Not yet recruiting
N/A
194
 
granules of xianxiongchengqi decoction ;Valsartan capsule
Affiliated Hospital of Shandong University of TCM; Affiliated Hospital of Shandong University of TCM, Shandong development and reform commission
Essential hypertension
 
 
ChiCTR2000031103: Clinical study and Mechanism of Huanglian jiedu decoction in the treatment of Hypertension with hyperactivity of liver fire Syndrome based on Network Pharmacology

Not yet recruiting
N/A
194
 
granules of Huanglianjiedu decoction ;Valsartan capsule
Affiliated Hospital of Shandong University of TCM; Affiliated Hospital of Shandong University of TCM, Shandong development and reform commission
Essential hypertension
 
 
ChiCTR2000031117: A randomized controlled trial for the clinical effect of Wu-Mei-Wan Decoction in the treatment of primary hypertension with upper heat and lower cold syndrome

Not yet recruiting
N/A
194
 
granules of ;Valsartan capsule
Affiliated Hospital of Shandong University of TCM; Affiliated Hospital of Shandong University of TCM, Shandong development and reform commission
Essential hypertension
 
 
ChiCTR2000031157: Mechanism and Clinical research of Zhenganxifeng dispensing granule decoction for treatment of hypertension with Yin Deficiency and Yang Hyperactivity Syndrome based on network pharmacology

Not yet recruiting
N/A
194
 
Zhenganxifeng dispensing granule decoction ;Valsartan capsule
Affiliated Hospital of Shandong University of TCM; Affiliated Hospital of Shandong University of TCM, Shandong development and reform commission
Essential hypertension
 
 
ChiCTR2000033890: Clinical efficacy evaluation of Qingda Granule in the treatment of hypertension (grade 1, low to medium-risk) patients: a multicenter, randomized, double-blind, double-simulated, parallel-controlled, non-inferiority clinical study

Recruiting
N/A
552
 
Qingda granules + Valsartan capsule simulation agent: Qingda granules 1 bag/time, 2 times/day; Valsartan capsule analog, 1 capsule/day. ;Valsartan capsule + Qingda granules simulation agent: Qingda granules simulation agent 1 bag/time, 2 times/day; Valsartan capsule, 1 capsule/day.
Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences; Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, The management
hypertension
 
 
ChiCTR1800020241: Investigation for Risk Factors of Membrane Nephropathy in Guangxi and Study for Intervention of Vitamin D

Recruiting
N/A
120
 
Active Vitamin D 0.5ug/day ;Valsartan capsule 160mg/day ;Active vitamin D 0.5ug / day + valsartan capsule 160mg / day
The People's Hospital of Guangxi Zhuang Autonomous Region; The People's Hospital of Guangxi Zhuang Autonomous Region, Science and Technology Bureau of Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region
Idiopathic membranous nephropathy
 
 
ChiCTR2000039700: A single center randomized controlled clinical study on the treatment of Children with Purpura nephritis with Huai-Qi-Huang Granules

Recruiting
N/A
10
 
Huaiqihuang ;valsartan
Children's Hospital, Zhejiang University School of Medicine; Children's Hospital, Zhejiang University School of Medicine, Chen Xiaoping Foundation for the Development of Science and Technology of Hubei Province
Children with purpura nephritis
 
 
ChiCTR1900025409: Tangshenkang to prevent and treat diabetic nephropathy

Not yet recruiting
N/A
45
 
Tangshenkang + ACEI class of drugs (benazepril) ;ACEI (benazepril) + ARB drug (valsartan) ;ACEI class of drugs(benazepri)
Yangzhou University Medicine college; Yangzhou University Medicine college, Jiangsu Provincial Traditional Chinese Medicine Bureau Science and Technology Project Plan
Diabetic nephropathy
 
 
ChiCTR1900026018: Wenshen-Huatan-Quyu particle combined with valsartan for benign hypertensive nephrosclerosis: a randomized controlled trial

Not yet recruiting
N/A
70
 
Wenshen-Huatan-Quyu particle plus valsartan ;Wenshen-Huatan-Quyu placebo plus valsartan
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai Science and Technology Commission Guiding Project (No. 19401943700)
Chironic kidney disease
 
 
ChiCTR1800015179: Clinical effect of Mudan granule on diabetic microvascular complication.

Not yet recruiting
N/A
1140
 
Diovan ;Mudan granule ;Diovan and Mudan granule ;Diovan ;Diovan ;Diovan and Mudan granule
Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University; Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, None
diabetic microvascular complication
 
 
ARNI-HD, ChiCTR2100042186: Application of sacubarb / valsartan in maintenance hemodialysis patients with preserved ejection fraction heart failure: a single arm study

Recruiting
N/A
200
 
sacubarb/valsartan taken
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences; Peking Union Medical College Hospital, raise the fund independently
End Stage Renal Disease, Heart Failure
 
 
AWARD-HF2, ChiCTR1900028191: Withdrawal of Neprilysin Inhibition for heart failure in ARNI responders with recovered ischemic cardiomyopathy

Not yet recruiting
N/A
50
 
continous administration ARNI ;stop ARNI, only taking Valsartan
Changzhou 2nd Hospital; Nanjing First Hospital, no sponsor
ischemic heart disease
 
 
ChiCTR2200064406: Effect of sarcubitril valsartan in antihypertension and improvement of prognosis of cardiovascular diseases in patients on hemodialysis

Recruiting
N/A
181
 
sarcubitril valsartan
Department of Nephrology Peking University First Hospital; Peking University First Hospital, Suzhou Industrial Park Xinxin Cardiovascular Health Foundation
N/A
 
 
ChiCTR2100053690: Clinical efficacy of combining Huaiqihuang Granules with ARB in the treatment of chronic glomerulonephritis (Qi and Yin deficiency type)-a prospective randomized controlled study

Recruiting
N/A
36
 
Valsartan Tablets combined with Huaiqihuang Granules ;Valsartan Tablets
the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine; the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Hubei Chen Xiaoping Science and Technology Development Foundation CXPJJH21002-202106
Chronic glomerulonephritis
 
 
ChiCTR2000035168: Evaluation The Influence of Duration after Sacubatril/valsartan Initiation on Short-term and Long-term Prognosis in Patients with Acute Heart Failure

Not yet recruiting
N/A
800
 
ACEI/ARB ;Sacubatril/valsartan
Zhongshan Hospital Fudan University; Zhongshan Hospital Fudan University, Other
acute heart failure
 
 
NCT06344247: Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Recruiting
N/A
48
RoW
RAS inhibitors:Losartan®️/Valsartan®️, dapagliflozin:Forxiga®️, simagliptin:Forxiga®️, Semaglutide®️
RenJi Hospital
Obesity, Chronic Kidney Diseases
09/25
12/25

Not yet recruiting
N/A
63
 
Chuanhuang No.1 prescription+ Valsartan ;valsartan
Shanghai Dong Fang Hospital; Shanghai Dong Fang Hospital, self-raised
Primary IgA nephropathy
 
 
ChiCTR2200056016: Evidence-based evaluation of Qidan Tangshen granule in the treatment of early diabetic kidney diease

Recruiting
N/A
200
 
Qidan Tangshen granule, Valsartan simulator ;Qidan Tangshen granule simulator, Valsartan
LongHua Hospital Shanghai University of Traditional Chinese Medicine; LongHua Hospital Shanghai University of Traditional Chinese Medicine, Science & Technology Department of Shanghai
Type 2 diabetic nephropathy
 
 
ChiCTR2200062663: A clinical study of traditional Chinese medicine combined with western medicine in treatment of primary IgA nephropathy (IgAN) in CKD stage 3

Not yet recruiting
N/A
63
 
oral valsartan ;Valsartan + Chuanhuang 1 prescription
Shanghai East Hospital (East Hospital Affiliated to Tongji University); Shanghai East Hospital (East Hospital Affiliated to Tongji University), Shanghai East Hospital (East Hospital Affiliated to Tongji University)
IgA nephropathy
 
 
NCT05271448: Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

Recruiting
N/A
600
RoW
Continue ACEI or ARBs ( Enalapril , Ramipril , Valsartan , Candesartan, Losartan ), Continue ACEI or ARBs, Hold ACEI or ARBs
An-Najah National University
Contrast-induced Nephropathy, Chronic Kidney Diseases, Ischemic Heart Disease
06/24
08/24
ChiCTR2300071967: Observation on the clinical efficacy of Shen Ge San combined with enhanced external counterpulsation in improving chronic heart failure

Recruiting
N/A
108
 
On the basis of standard Western medicine treatment (valsartan 40/80mg qd po, spironolactone 20mg qd/bid po, metoprolol 12.5mg/25mg qd/bid po;) combined with EECP treatment, take Shen Ge San twice a day, 3g each time; ;On the basis of standard Western medicine treatment (valsartan 40/80mg qd po, spironolactone 20mg qd/bid po, metoprolol 12.5mg/25mg qd/bid po;) combined with EECP, take a placebo twice a day, 3g each time;
Shanghai Jing'an District Shibei Hospital ; Shanghai Jing'an District Shibei Hospital, Shanghai Municipal Health Commission
chronic heart failure
 
 
ChiCTR2200065675: Clinical study on abdominal acupuncture in the treatment of heart and kidney yang deficiency syndrome of heart failure

Not yet recruiting
N/A
84
 
Conventional drug therapy (valsartan + metoprolol succinate + spironolactone + Furosemide)+ abdominal acupuncture ;Conventional drug therapy (valsartan + metoprolol succinate + spironolactone + Furosemide)
Beijing Mentougou Hospital of Traditional Chinese Medicine; Beijing Mentougou Hospital of Traditional Chinese Medicine, Capital's Funds for Health Improvement and Research(2022-3-7061)
heart failure
 
 
ChiCTR2300073557: Study on the effect of azilsartan on the early index of renal injury

Not yet recruiting
N/A
900
 
Azithartan 20mg/d ;Valsartan 80mg/d
Zhongshan Hospital, Fudan University; Zhongshan Hospital, Fudan University, Hengxin Funding
Hypertensive nephropathy
 
 
ChiCTR2300070218: Randomized controlled trial of Tangshenweining formula in treating diabetic nephropathy by improving vascular endothelial function

Recruiting
N/A
64
 
Tangshenweining formula + valsartan ;Placebo + Valsartan
Beijing Chaoyang Hospital, Capital Medical University; Beijing Chaoyang Hospital, Capital Medical University, Capital's Funds for Health Improvement and Research, Beijing, China (No. CFH 2022-3-20311)
Diabetic nephropathy
 
 
NCT03535376: Bariatric Surgery and Pharmacokinetics of Valsartan

Recruiting
N/A
12
Europe
Valsartan, Diovan, Kalpress, Tareg, Provas, Miten
Norwegian University of Science and Technology, St. Olavs Hospital, Volvat Medisinsk Senter Stokkan, Namsos Hospital, Alesund Hospital
Obesity, Morbid
10/26
10/26
ChiCTR2000035619: A prospective, multicenter registration study to evaluate the coding, prognosis and intervention in patients of heart failure with preserved ejection fraction

Not yet recruiting
N/A
615
 
Standard treatment for heart failure + Sacubatril valsartan ;Standard treatment for heart failure + Valsartan
Zhongshan Hospital, Fudan University; Zhongshan Hospital, Fudan University, Major clinical research project of Shanghai Shenkang Hospital Development Center
Heart Failure with Preserved Ejection Fraction
 
 

Download Options